Target intelligence / Profile preview

Capsular polysaccharide of Streptococcus pneumoniae serotype 7F (CPS 7F)

Target
CPS 7F
Molecular classification
Bacterial capsular polysaccharide, Antigen, Virulence factor
01

Overview

The capsular polysaccharide of Streptococcus pneumoniae serotype 7F is a complex carbohydrate polymer that forms the outermost protective layer of the bacterium. It serves as a primary virulence factor by shielding the pathogen from the host's immune system, specifically by preventing opsonization and subsequent phagocytosis by immune cells like neutrophils. Serotype 7F is recognized as a highly invasive strain, frequently associated with severe invasive pneumococcal diseases (IPD) such as meningitis, bacteremia, and pneumonia, particularly in children and the elderly. Due to its clinical significance, this polysaccharide is a key antigenic target in several multivalent pneumococcal vaccines, including conjugate vaccines like PCV13, PCV15, and PCV20, as well as the polysaccharide vaccine PPSV23. These vaccines work by inducing the production of serotype-specific antibodies that bind to the 7F polysaccharide, thereby facilitating the clearance of the bacteria through opsonophagocytosis.

Other names
Serotype 7F capsular polysaccharidePnPs 7FPneumococcal polysaccharide 7FStreptococcus pneumoniae type 7F polysaccharidePn7F
02

Mechanism of action

Induction of a serotype-specific humoral immune response where vaccine-derived antibodies (IgG) bind to the capsular polysaccharide, promoting opsonization and subsequent clearance by phagocytic cells.

03

Biological functions

Immune evasionBacterial encapsulationVirulenceInhibition of opsonophagocytosis
04

Disease associations

Invasive pneumococcal diseasePneumoniaMeningitisBacteremiaSepsisOtitis media
05

Safety considerations

Serotype replacement (emergence of non-vaccine serotypes)Injection site reactionsHypersensitivity reactions
06

Interacting drugs

Pneumococcal 10-valent conjugate vaccine (Synflorix)

4 more in the full profile.

07

Biomarkers

Serotype-specific IgG antibody concentrationOpsonophagocytic activity (OPA) titer

Beyond the preview

Go deeper on Capsular polysaccharide of Streptococcus pneumoniae serotype 7F (CPS 7F).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Capsular polysaccharide of Streptococcus pneumoniae serotype 7F (CPS 7F).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call